Jan 04,2023

Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States

Pear Therapeutics, Inc. today announced the expansion of its collaboration with Spero Health, an integrated healthcare services organization specializing in local and affordable outpatient care for individuals suffering from substance use disorders, to provide adults suffering from substance use disorder (SUD) and opioid use disorder (OUD) access to reSET® and reSET-O®, for each respective condition. The expansion is part of Spero Health’s commitment to increase patient engagement and retention in recovery by offering FDA-authorized innovative treatment options.

COLLABORATION PARTNERSHIP

#institution

#pdt

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 10,2023

Hygieia Expands to Arizona, as Endocrinology Associates, PA, Joins d-Nav® Insulin Management Clinical Partnership Program

Hygieia, a provider of digital therapeutics for insulin management, has added Endocrinology Associates, PA, in Scottsdale and Chandler, AZ, as a clinical partner. This makes Hygieia’s d-Nav® autonomous insulin therapy service available to patients with type 2 diabetes in Arizona. Partnership model gives physicians better tools for insulin therapy and offers new reimbursement opportunities

COLLABORATION PARTNERSHIP

#institution

#software

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Jan 10,2023

Theranica Enters Into Agreement With Dr. Reddy’s for Commercializing Nerivio® in India

Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other pain conditions, today announced a strategic license and supply agreement with Dr. Reddy's Laboratories Ltd., a global pharmaceutical company, for the exclusive marketing and distribution of FDA-approved Nerivio® in India, subject to completion of the regulatory approval process in India. Under the terms of the agreement, Dr. Reddy's will be responsible for the regulatory approval of Nerivio in India, after which it will exclusively market Nerivio in India, manufactured and supplied by Theranica.

COLLABORATION PARTNERSHIP

#institution

#pdt

#connected device

View Analyst & Ambassador Comments
Go to original news
Jan 12,2023

California Department of Health Care Services awards Contract to Pear Therapeutics to Support the Recovery Incentives Program

The pilot program will allow eligible Medi-Cal members, across 24 counties in California, to take part in a structured 24-week outpatient program that will be followed by at least six months of additional recovery support services. Pear Therapeutics will partner with DHCS to deliver, implement, and manage this program, specifically by managing the electronic tracking and distribution of incentives to Medi-Cal members who participate in this contingency management pilot.

COLLABORATION PARTNERSHIP

#institution

#pdt

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 23,2023

Orlando Health Selects Biofourmis to Enable Optimal Hospital-Level Care in Patients’ Homes

Biofourmis, announced today a multi-year agreement with Orlando Health, a non-profit healthcare organization that serves the southeastern United States. Orlando Health will leverage Biofourmis’ solution to support its program, which will enable providers across Central Florida to safely and effectively deliver hospital-level care to patients in their homes.

COLLABORATION PARTNERSHIP

#institution

#rpm

#virtual care

View Analyst & Ambassador Comments
Go to original news
Jan 26,2023

Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders

This initiative is designed to provide eligible adults suffering from substance use disorder (SUD) and opioid use disorder (OUD) access to reSET® and reSET-O®. BrightView, an innovative and patient-focused leader in SUD and OUD treatment, began piloting Pear’s products in its centers across six locations in Kentucky and Ohio in early 2022, and intends to expand the initiative across Kentucky, Ohio, Delaware, Massachusetts, and Virginia. BrightView currently has over 80 locations across 8 states.

COLLABORATION PARTNERSHIP

#institution

#pdt

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 22,2022

Leading International Wellness Company Selects Dario as Partner for Musculoskeletal Health Improvement Program

DarioHealth Corp. (NASDAQ: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today a new partnership with ECES, a leading international wellness company, to deploy Dario Move throughout Greece and Cyprus as part of a planned government sponsored initiative. The program will launch in early 2023 with a mandate to screen a minimum of 50,000 citizens in support of improving musculoskeletal health of the Greek and Cyprus populations.

COLLABORATION PARTNERSHIP

#institution

#coaching

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 09,2020

Two leading university hospitals implement Kaiku Health in Central Europe

Kaiku Health is strengthening its foothold in Central Europe as the Geneva University Hospitals (HUG) in Switzerland and University Hospital Schleswig-Holstein Lübeck in Germany will implement Kaiku Health in the symptom management and patient-reported outcome monitoring of their cancer patients. Kaiku Health was piloted at the Geneva University Hospitals (HUG) in 2019. The platform will be gradually provided for all patients who receive chemotherapy for local or metastatic breast, colorectal or lung cancer.

COLLABORATION PARTNERSHIP

#institution

#rpm

View Analyst & Ambassador Comments
Go to original news
Feb 10,2020

Autism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to Care

Autism Learning Partners (“ALP”), a national leader in the treatment of autism and other developmental disabilities, and Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today a partnership designed to accelerate the diagnosis of autism to enable interventions earlier. Through this partnership, ALP will provide parents the Cognoa for Child Development app. By using the Cognoa app, parents will receive information assessing their child’s developmental progress as well as personalized evidence-based activities to support their child’s development across key areas including gross motor skills and social emotional development. Additionally, Cognoa will enable ALP clinicians to identify children at risk for autism spectrum disorder (ASD) and direct children to the most appropriate next steps, including expedited diagnostic evaluations to ensure that children receive therapy services when needed.

COLLABORATION PARTNERSHIP

#institution

#mobile app

View Analyst & Ambassador Comments
Go to original news
Feb 24,2020

DarioHealth Digital Diabetes Management System is Now Available at Albertsons

DarioHealth announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes and hypertension on Albertsons Marketplace. Albertsons Companies is one of the largest retailers in the United States, with more than 2,000 grocery stores under well-known banners such as Albertsons, Safeway, Vons, Jewel-Osco, Shaw's, Acme, Tom Thumb, Randalls, United Supermarkets, Pavilions, Star Market, Haggen and Carrs. Through more than 1,700 in-store pharmacies across the country. Dario™ will be offering its innovative "Membership-in-a-Box" package which is designed to reach consumers with chronic conditions such as diabetes who shop at retail stores.

COLLABORATION PARTNERSHIP

#institution

#mobile app

#connected device

View Analyst & Ambassador Comments
Go to original news
Subscribe to INSTITUTION